More Litigation news More news in Maryland Find Litigation lawyers in Maryland
On May 24, 2026, a major lawsuit was filed in Maryland against a prominent pharmaceutical company for its role in the ongoing opioid crisis. The lawsuit, filed by a coalition of Maryland-based organizations and individuals, accuses the company of contributing to the widespread addiction and overdose deaths that have plagued the state in recent years.According to the plaintiffs, the pharmaceutical company aggressively marketed highly addictive opioid painkillers, such as OxyContin and Percocet, while downplaying the risks of addiction and overdose. The lawsuit alleges that the company's deceptive marketing tactics led to a surge in opioid prescriptions and subsequent addiction rates in Maryland.The plaintiffs are seeking damages for the costs incurred by the state and its residents as a result of the opioid crisis, including healthcare expenses, law enforcement costs, and lost productivity. They are also calling for accountability from the pharmaceutical company for its role in fueling the crisis and are urging for better regulation of opioid prescribing practices.This lawsuit is just the latest in a wave of litigation against pharmaceutical companies across the country for their role in the opioid epidemic. In recent years, several major companies have been ordered to pay billions of dollars in settlements and damages for their deceptive marketing practices and failure to adequately warn about the risks of opioid addiction.The outcome of this lawsuit could have far-reaching implications for the pharmaceutical industry and the way prescription opioids are marketed and prescribed in the future. Advocates hope that holding companies accountable for their actions will help prevent future public health crises and ensure justice for those who have been affected by the devastating effects of opioid addiction in Maryland.